Navigating End-of-Life Decisions in Neonatal Care: What Factors Really Matter?
"A new study uncovers the complex factors influencing withdrawal of life support for infants with severe brain injury, revealing disparities and ethical considerations."
Decisions surrounding end-of-life care are among the most difficult that families and healthcare providers face, especially when the patient is a newborn. For infants with severe hypoxic-ischemic encephalopathy (HIE), a condition resulting from oxygen deprivation to the brain, these decisions often involve considering the withdrawal of life support (WLS).
While therapeutic hypothermia (TH) has improved survival rates for infants with HIE, the difficult reality remains that some infants will sustain severe brain injury. In these cases, families and medical teams must weigh the potential for long-term disability against the continuation of life-sustaining measures. Understanding the factors that influence these decisions is crucial for ensuring compassionate and equitable care.
A recent study published in Pediatric Neurology delves into the complexities surrounding WLS decisions in infants with HIE. By analyzing data from a large cohort of newborns, the researchers identified key medical and socioeconomic factors that impact these difficult choices. This article will break down the study's findings, explore their implications, and discuss the ethical considerations for families and healthcare professionals.
Neonatal Encephalopathy’s Impact
Neonatal encephalopathy (NE) is a major cause of death and long-term severe disability in term and near-term infants, including epilepsy and cerebral palsy. Hypoxic-ischemic encephalopathy (HIE) is its single most common cause, although infection and other causes can also lead to NE. HIE results from impaired oxygen delivery and reduced blood flow to the neonatal brain during the perinatal period and remains a leading cause of neonatal mortality and long-term neurodevelopmental disability worldwide.
Recognizing Neonatal HIE
Neonatal HIE is a type of brain damage caused by a lack of oxygen to the brain before or shortly after birth. Problems during labor and delivery can contribute, but the exact cause is often unknown. The provided clinical-pathway source cites research on therapeutic hypothermia and the importance of starting treatment promptly, including the study title “Time is brain: starting therapeutic hyp...”; the available excerpt does not specify the pathway’s full treatment steps or limitations.
Defining Neonatal Encephalopathy
Neonatal encephalopathy in term and near-term infants is defined as altered neurologic function in a newborn, characterized by altered consciousness and abnormal tone and reflexes. A separate clinical description defines it as a heterogeneous syndrome of disturbed neurologic function in the earliest days of life in infants born at or beyond 35 weeks of gestation, manifested by reduced consciousness or seizures. The excerpts describe these definitions but do not identify historical milestones or foundational discoveries.
Unveiling the Factors Influencing Withdrawal of Life Support in Neonatal HIE
The study, conducted by researchers on behalf of the Children's Hospitals Neonatal Consortium (CHNC), analyzed data from 1,925 infants born at or after 36 weeks of gestation with HIE who underwent therapeutic hypothermia between 2010 and 2016. The infants were cared for in one of the Children's Hospitals Neonatal Database (CHND) NICUs. The researchers compared infants who died following withdrawal of life support (WLST) to infants with severe HIE who survived (requiring tube feedings at discharge). The study revealed several important factors associated with the decision to withdraw life support:
- Socioeconomic Disparities: Infants from families with public insurance were more likely to have life support withdrawn compared to those with private insurance. Additionally, families from the Southern United States were less likely to choose withdrawal of life support.
- Severity of Brain Injury: While severe brain injury, as indicated by EEG and MRI results, was a significant factor, these tests were not always consistently performed or used in the decision-making process. This suggests that other factors beyond objective measures of brain injury play a role.
- Early Timing: In many cases, withdrawal of life support was considered relatively early in the infant's course, sometimes before comprehensive neurological assessments could be completed.
Prognosis and Family Conversations
The study “Predictive value of the Thompson score for short-term adverse outcomes in neonatal encephalopathy” notes that withdrawal of life-sustaining treatment may be considered when severe neurological sequelae and special health care needs are expected, making reliable prediction of poor outcomes important. The ALIGN Framework describes outcome conversations as a way to help families prepare for life at home, consider a child’s future quality of life, and make health-care decisions. It also reports that little is known about how caregivers and patients prefer outcome information to be shared, despite the complexity and frequency of these conversations. A rural-states study used a composite of in-hospital mortality and gray matter injury score ≥ 9.5 to represent severe outcomes that differ primarily by parental decision making.
Implications and Future Directions: Towards More Equitable and Compassionate Care
This study underscores the need for a more nuanced and equitable approach to end-of-life decision-making in neonatal HIE. Healthcare providers should be aware of the potential influence of socioeconomic factors and strive to provide all families with comprehensive information and support, regardless of their background or location.
HIE Burden and Treatment
The University of Wisconsin consensus care guideline reports that HIE occurs in 1–3 per 1,000 term births and accounts for 22% of neonatal deaths worldwide. It describes high morbidity and mortality among affected infants. The guideline identifies therapeutic hypothermia as a standard neuroprotective strategy that can improve outcomes related to death and disability.
Limits of Current Neuroprotection
A review published December 1, 2025, describes hypoxic-ischemic neonatal encephalopathy as a leading cause of global neonatal mortality. It reports that various neuroprotective strategies have been explored over the past decades, while therapeutic hypothermia remains the only clinically approved intervention to date. The review also outlines emerging and adjunctive treatment modalities beyond therapeutic hypothermia.
Further research is needed to explore the reasons behind the observed disparities and to develop interventions that promote more informed and consistent decision-making. This may include:
<ul> <li>Developing standardized protocols for neurological assessment and communication with families.</li> <li>Providing culturally sensitive counseling and support services.</li> <li>Addressing systemic biases in healthcare access and resource allocation.</li></ul> By addressing these challenges, we can ensure that all infants with HIE receive the best possible care and that end-of-life decisions are made in a way that is both compassionate and ethically sound.